180 Life Sciences Corp. Files 8-K on Executive and Director Changes
Ticker: FRMM · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-governance, filing
Related Tickers: ATNF
TL;DR
180 Life Sciences filed an 8-K on 7/11/25 for exec/director changes & compensation.
AI Summary
On July 11, 2025, 180 Life Sciences Corp. filed an 8-K report detailing changes in its board of directors and executive officers. The filing also addresses compensatory arrangements for certain officers and includes other events and financial statements. The company, formerly known as KBL Merger Corp. IV, is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides crucial updates on the company's leadership and governance, which can impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in executive and director positions can signal shifts in company strategy or internal dynamics, warranting closer investor scrutiny.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former Company Name
- July 11, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors and executive officers?
The filing indicates changes in directors and officers, but the specific details of these changes are not provided in the provided text excerpt.
What is the nature of the compensatory arrangements mentioned?
The filing mentions compensatory arrangements of certain officers, but the specific details of these arrangements are not elaborated in the provided text excerpt.
What other events are reported in this 8-K filing?
Besides changes in directors and officers and compensatory arrangements, the filing also includes 'Other Events' and 'Financial Statements and Exhibits'.
When was 180 Life Sciences Corp. formerly known as KBL Merger Corp. IV?
The date of the name change from KBL Merger Corp. IV to 180 Life Sciences Corp. was November 15, 2016.
What is the Standard Industrial Classification (SIC) code for 180 Life Sciences Corp.?
The SIC code for 180 Life Sciences Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding 180 Life Sciences Corp. (FRMM).